...Collaboration with the National Cancer Institute’s (NCI...
Castle Biosciences, Inc. today announced new data from two studies demonstrating the potential of DecisionDx®-Melanoma and DecisionDx®-UM to accurately stratify risk of death from melanoma (cutaneous melanoma (CM) and uveal ...